Cystatin C for managing diuretic-induced kidney dysfunction in MMVD dogs

키워드

참고문헌 (35)

1. Abrahamson M, "Structure and expression of the human cystatin C gene", Biochem J, 268, pp.287~294 (1990)
2. Atkins C, "Guidelines for the diagnosis and treatment of canine chronic valvular heart disease", J Vet Intern Med, 23, pp.1142~1150 (2009)
3. Atkins CE, "Pharmacologic management of myxomatous mitral valve disease in dogs", J Vet Cardiol, 14, pp.165~184 (2012)
4. Brown S, "Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats", J Vet Intern Med, 21, pp.542~558 (2007)
5. Brown S, "Consensus recommendations for standard therapy of glomerular disease in dogs", J Vet Intern Med, 27(Suppl 1), pp.S27~S43 (2013)[DOI]
6. Brown S, "Introduction from the International Renal Interest Society", J Vet Intern Med, 27(Suppl 1), pp.S1~ (2013)
7. Currie G, "Proteinuria and its relation to cardiovascular disease. International journal of nephrology and renovascular disease", Int J Nephrol Renovasc Dis, 21, pp.13~24 (2013)
8. Dharnidharka VR, "Serum cystatin C is superior to serum creatinine as a marker of kidney function : a meta-analysis", Am J Kidney Dis, 40, pp.221~226 (2002)
9. Drum MG, "Principles and applications of therapeutic exercises for small animals", Vet Clin North Am Small Anim Pract, 45, pp.73~90 (2015)
10. Ellison DH, "Diuretic therapy and resistance in congestive heart failure", Cardiology, 96, pp.132~143 (2001)
11. Elmahdy MF, "Diuretics increase Blood Creatinine in the Treatment of Hypertension", Medico-Legal Update, 21, pp.780~785 (2021)
12. Felker GM, "Loop diuretics in heart failure", Heart Fail Rev, 17, pp.305~311 (2012)
13. Ghys L, "Cystatin C : a new renal marker and its potential use in small animal medicine", J Vet Intern Med, 28, pp.1152~1164 (2014)
14. Hall J, "Serum concentrations of symmetric dimethylarginine and creatinine in dogs with naturally occurring chronic kidney disease", J Vet Intern Med, 30, pp.794~802 (2016)
15. Hall J, "Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease", J Vet Intern Med, 28, pp.1676~1683 (2014)
16. Hansson K, "Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement", Vet Radiol Ultrasound, 43, pp.568~575 (2002)
17. Herget-Rosenthal S, "How to estimate GFR-serum creatinine, serum cystatin C or equations?", Clin Biochem, 40, pp.153~161 (2007)
18. Huerta A, "Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients : potential role of altered collagen metabolism", J Hypertens, 34, pp.130~138 (2016)
19. Iwasa N, "Serum cystatin C concentration measured routinely is a prognostic marker for renal disease in dogs", Res Vet Sci, 119, pp.122~126 (2018)
20. Keene BW, "ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs", J Vet Intern Med, 33, pp.1127~1140 (2019)
21. Koenig W, "Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events : more than simply a marker of glomerular filtration rate", Clin Chem, 51, pp.321~327 (2005)
22. Laterza OF, "Cystatin C : an improved estimator of glomerular filtration rate?", Clin Chem, 48, pp.699~707 (2002)
23. Liang KV, "Acute decompensated heart failure and the cardiorenal syndrome", Crit Care Med, 36(Suppl 1), pp.S75~S88 (2008)[DOI]
24. Luo J, "Cystatin C and cardiovascular or all-cause mortality risk in the general population : a meta-analysis", Clin Chim Acta, 450, pp.39~45 (2015)
25. Martinelli E, "Prospective evaluation of renal function in dogs with chronic mitral valve disease" (2020)
26. Miyagawa Y, "Evaluation of the measurement of serum cystatin C by an enzyme-linked immunosorbent assay for humans as a marker of the glomerular filtration rate in dogs", J Vet Med Sci, 71, pp.1169~1176 (2009)
27. Morgan KRS, "Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation", Vet J, 263, pp.105518~ (2020)
28. Nabity M, "Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early detection of chronic kidney disease in dogs", J Vet Intern Med, 29, pp.1036~1044 (2015)
29. 오세원, "Loop Diuretics in Clinical Practice", Electrolytes & Blood Pressure, 13(1), pp.17~21 (2015), 전해질고혈압연구회[DOI]
30. Pouchelon JL, "Cardiovascular-renal axis disorders in the domestic dog and cat : a veterinary consensus statement", J Small Anim Pract, 56, pp.537~552 (2015)
31. Ronco C, "Cardiorenal syndrome", J Am Coll Cardiol, 52, pp.1527~1539 (2008)
32. Shlipak MG, "Clinical and subclinical cardiovascular disease and kidney function decline in the elderly", Atherosclerosis, 204, pp.298~303 (2009)
33. Shlipak MG, "Cystatin C and the risk of death and cardiovascular events among elderly persons", N Engl J Med, 352, pp.2049~2060 (2005)
34. "IRIS staging of CKD" (2023)[URL]
35. Zhao R, "Serum Cystatin C and the risk of coronary heart disease in ethnic Chinese patients with normal renal function", Lab Med, 47, pp.13~19 (2016)

관련 논문AI추천